John de Kruif

Chief Tech/Sci/R&D Officer en MERUS N.V. .

60 años

Health Technology

Consumer Services

Cargos activos de John de Kruif

Empresas	Cargo	Inicio	Fin
MERUS N.V.	Chief Tech/Sci/R&D Officer	01/04/2007	-

Empresas	Cargo	Inicio	Fin
Crucell NV Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.	Corporate Officer/Principal	01/10/2000	01/10/2006

University of Utrecht

Doctorate Degree

Internacional

Países Bajos

Operativa

Chief Tech/Sci/R&D Officer	1
Corporate Officer/Principal	1
Doctorate Degree	1

Sectorial

Health Technology	3
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	1
MERUS N.V.	Health Technology

Empresas privadas	1
Crucell NV Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.	Health Technology

Empresas privadas

Health Technology